Cargando…
Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura
Autores principales: | Scully, Marie, Hibbard, Christopher, Ewenstein, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769974/ https://www.ncbi.nlm.nih.gov/pubmed/29344548 http://dx.doi.org/10.18632/oncoscience.380 |
Ejemplares similares
-
Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura()
por: Thomas, Mari R., et al.
Publicado: (2015) -
Psychometric evaluation of a patient-reported outcomes instrument for congenital thrombotic thrombocytopenic purpura
por: Oladapo, Abiola, et al.
Publicado: (2023) -
ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023) -
Bethesda Assay for Detecting Inhibitory Anti-ADAMTS13 Antibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Vendramin, Chiara, et al.
Publicado: (2018) -
Patient Experience with Congenital (Hereditary) Thrombotic Thrombocytopenic Purpura: A Conceptual Framework of Symptoms and Impacts
por: Oladapo, Abiola O., et al.
Publicado: (2019)